Cite
HARVARD Citation
Galimberti, V. et al. (2018). Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet oncology. 19 (10), pp. 1385-1393. [Online].